<DOC>
	<DOCNO>NCT00652951</DOCNO>
	<brief_summary>The purpose trial evaluate immunogenicity safety pneumococcal conjugate vaccine co-administered DTPa-IPV-Hib DTPa-HBV-IPV/Hib infant three-dose primary immunisation course first 6 month life booster dose 11-12 month age . The impact pneumococcal conjugate vaccine nasopharyngeal carriage S. pneumoniae H. influenzae child first two year life also assess . The Protocol Posting update order comply FDA Amendment Act , Sep 2007 .</brief_summary>
	<brief_title>Co-administration Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib</brief_title>
	<detailed_description />
	<mesh_term>Streptococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Subjects investigator believe parents/guardian ( ) comply requirement protocol ( e.g. , completion diary card , return followup visit ) enrol study . A male female , include , 612 week ( 4290 day ) age time first vaccination . Written inform consent obtain parent guardian ( ) subject . Free obvious health problem establish medical history clinical examination enter study . Born gestation period least 36 week . Use investigational nonregistered product ( drug vaccine ) study vaccine ( ) within 30 day precede first dose study vaccine , plan use study period . Concurrently participate another clinical study , time entire study period , subject expose investigational noninvestigational product ( pharmaceutical product device ) . Chronic administration ( defined 14 day ) immunosuppressant immunemodifying drug since birth . Planned administration/administration vaccine foreseen study protocol period start one month ( 30 day ) one month ( 30 day ) dose study vaccine . Previous vaccination diphtheria , tetanus , pertussis , polio , hepatitis B , Haemophilus influenzae type b and/or Streptococcus pneumoniae . Children hepatitis B vaccination require accord local recommendation History intercurrent diphtheria , tetanus , pertussis , hepatitis B , polio , Haemophilus influenzae type b disease . History allergic disease reaction likely exacerbate component vaccine . History neurologic disorder seizure . Acute disease time enrolment . Any confirm suspected immunosuppressive immunodeficient condition base medical history physical examination A family history congenital hereditary immunodeficiency . Major congenital defect serious chronic illness . Administration immunoglobulins and/or blood product since birth plan administration study period .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>